9.70 USD
▲-0.30+1.36%
盘后 9.49 -0.84%
2026-08-03
市值
$7.90M
市盈率
—
EPS
-1.85
股息率
—
52 周区间
6.00 – 44.70
成交量
18.52K
Beta
0.18
目标价
—
52W 低 6.0052W 高 44.70
价格走势
公司简介
Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium ...